Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FX3M1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,796
Award facts
- Contract value 100% obligated
- $13,795.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,795.96 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed price delivery order with no set-aside designation, issued on November 6, 2025, with an ultimate completion date of November 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Repatha is a PCSK9 inhibitor used for treating high cholesterol and reducing cardiovascular disease risk, particularly in patients with familial hypercholesterolemia. This delivery order exemplifies AmerisourceBergen's critical role in supplying specialty pharmaceutical products to support military healthcare systems and the Defense Health Agency. As a competitively awarded non-set-aside contract, this order demonstrates the company's continued capability to meet federal medical procurement requirements across its extensive portfolio of brand-name and generic medications, vaccines, and medical devices that support military personnel, veterans, and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FX3M1?
SPE2DR26FX3M1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FX3M1 worth?
The government has obligated $13,796 on SPE2DR26FX3M1.
Is contract SPE2DR26FX3M1 an order under another contract?
Yes. SPE2DR26FX3M1 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX3M1 competed?
The extent of competition for SPE2DR26FX3M1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award